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https://doi.org/10.1016/j.celrep.2020.108262SUMMARYCurrent models of mRNA turnover indicate that cytoplasmic degradation is coupled with translation. Howev-
er, our understanding of themolecular events that coordinate ribosome transit with themRNAdecaymachin-
ery is still limited. Here, we show that 4EHP-GIGYF1/2 complexes trigger co-translational mRNA decay. Hu-
man cells lacking these proteins accumulatemRNAswith prominent ribosome pausing. They include, among
others, transcripts encoding secretory andmembrane-bound proteins or tubulin subunits. In addition, 4EHP-
GIGYF1/2 complexes fail to reduce mRNA levels in the absence of ribosome stalling or upon disruption of
their interaction with the cap structure, DDX6, and ZNF598. We further find that co-translational binding of
GIGYF1/2 to the mRNA marks transcripts with perturbed elongation to decay. Our studies reveal how a
repressor complex linked to neurological disorders minimizes the protein output of a subset of mRNAs.INTRODUCTION
Regulation of protein synthesis throughout the translation cycle
safeguards the production of an optimal proteome. Changes in
ribosome dynamics during elongation are required to fine-tune
co-translational protein folding and regulate mRNA stability (Han-
son and Coller, 2018; Hu et al., 2009; Radhakrishnan and Green,
2016). Factors such as codon or nascent peptide composition,
secondary structures, ribosome-associated factors, defective ri-
bosomes, and damaged or improperly processed mRNAs influ-
ence ribosome movement on the open reading frame (ORF) (re-
viewed in Buskirk and Green, 2017; Joazeiro, 2017).
Codon optimality is a conserved evolutionary mechanism that
affects mRNA stability in a translation-dependent manner (Han-
son and Coller, 2018). mRNAs enriched in slow decoding (non-
optimal) codons tend to be more unstable than those enriched
in fast decoding (optimal) codons (Presnyak et al., 2015). In the
unstable transcripts, the slow translating ribosomes are recog-
nized by the RNA helicase DDX6 and the CCR4-NOT complex,
which then trigger mRNA decay (Buschauer et al., 2020; Rad-
hakrishnan et al., 2016).
Translation-coupledmechanisms also control mRNA stability in
response to the accumulation of unwanted or potentially cytotoxic
proteins. Tubulin mRNAs are decayed in response to excess de-
polymerized tubulin (Cleveland et al., 1981; Gasic et al., 2019; GayC
This is an open access article under the CC BY-Net al., 1989; Pachter et al., 1987). Binding of tetratricopeptide pro-
tein 5 (TTC5) to an N-terminal motif of tubulin activates, by yet un-
identified factors, the decay of the ribosome-bound mRNA (Lin
et al., 2020). Similarly, quality-control checkpoints sense defects
in protein targeting to the endoplasmic reticulum (ER) and initiate
mRNA degradation. Failure in the interaction of the signal recog-
nition particle (SRP) with the signal sequence of the nascent pro-
tein or the receptor at the ERmembrane results in the recruitment
of the decay machinery to the translating mRNA (Karamyshev
et al., 2014; Lakshminarayan et al., 2020; Pinarbasi et al., 2018).
The molecular details of co-translational decay of secretome-
associated mRNAs remain unclear.
Damaged or improperly processed mRNAs are also co-trans-
lationally degraded. Disruption of elongation in faulty transcripts
causes ribosome stalling and collision, decreases translation,
and has the potential to induce proteotoxic stress (Simms
et al., 2017a). Thus, cells evolved surveillance mechanisms
that coordinate the degradation of the truncated protein prod-
ucts and ribosome rescue with mRNA degradation (reviewed in
Brandman and Hegde, 2016; Joazeiro, 2019; Simms et al.,
2017a). Recognition and ubiquitination of the collided ribosomes
by the E3 ubiquitin ligase ZNF598 (Garzia et al., 2017; Ikeuchi
et al., 2019; Juszkiewicz et al., 2018; Juszkiewicz and Hegde,
2017; Simms et al., 2017b; Sundaramoorthy et al., 2017) acti-




OPEN ACCESSZNF598 binds to the Grb10-interacting GYF (glycine-tyrosine-
phenylalanine) domain proteins 1 and 2 (GIGYF1/2) that form a
translational repressor complex with the cap-binding eIF4E-ho-
mologous protein (4EHP) (Morita et al., 2012). The GYF domain
of GIGYF1/2 binds to proteins containing Pro-Pro-Gly-F motifs
(F, hydrophobic amino acid with the exception of tryptophan),
such as ZNF598, tristetraprolin (TTP), or the microRNA
(miRNA)-induced silencing-complex-associated TNRC6 pro-
teins (Fu et al., 2016; Morita et al., 2012; Schopp et al., 2017).
These interactions integrate the 4EHP-GIGYF1/2 complexes in
miRNA-mediated gene silencing, regulate cytokine production,
and control gene expression during embryonic development
(Fu et al., 2016; Giovannone et al., 2009; Kryszke et al., 2016;
Morita et al., 2012; Schopp et al., 2017; Tollenaere et al.,
2019). Together with the CCR4-NOT deadenylase complex
and DDX6, 4EHP and GIGYF1/2 repress translation initiation
and elicit mRNA decay (Amaya Ramirez et al., 2018; Peter
et al., 2019; Ruscica et al., 2019).
Despite the interaction with ZNF598, GIGYF1/2 and 4EHP
have not been associated with translational surveillance. Using
translatome and transcriptome analysis, we explored the role
of 4EHP-GIGYF1/2 complexes in the regulation of translation
and mRNA stability. Our results highlight a role for this repressor
complex in co-translational degradation of mRNAs, of which
many encode secreted and membrane-bound proteins.
Together with DDX6 and GYF-domain binding proteins, 4EHP
and GIGYF1/2 induce decay of mRNAs with disturbed elonga-
tion. Our studies indicate that 4EHP and GIGYF1/2 are part of
the cellular machinery that selectively reduces the abundance
of actively translating mRNAs to fine-tune protein synthesis.
RESULTS
4EHP-GIGYF1/2 Complexes Regulate the Abundance of
mRNAs Encoding Secreted and Membrane-Bound
Proteins
To identify mRNAs regulated by 4EHP and GIGYF1/2, we stud-
ied genome-wide translational changes by using ribosome
profiling (Ingolia et al., 2009). Isolation and identification of ribo-
some-protected fragments coupled to transcriptome analysis
were performed in control (Ctrl), CRISPR-Cas9-engineered GI-
GYF1/2 null (knockout [KO]) (Peter et al., 2017), and 4EHP null
(Räsch et al., 2020) HEK293T cells (Figures S1A and S1B). The
experiments were reproducible as ribosomal footprints (Ribo-
seq) and RNA sequencing (RNA-seq) library replicates clustered
together (Figures S1C and S1D).
To detect variations in translational efficiency (TE) across
experimental conditions, genes were plotted according to
changes inmRNA abundance and ribosome occupancy (Figures
1A and 1B). Only a small subset of mRNAs showed altered TE in
the absence of 4EHP (n = 24) or GIGYF1/2 (n = 7) (Figures 1A, 1B,
S1E, and S1F; Table S1). However, in comparison to Ctrl cells,
497 and 341 mRNAs exhibited increased abundance in 4EHP
null and GIGYF1/2 null cells, respectively (Tables S2 and S3). A
significant fraction of the mRNAs was commonly upregulated
in both null cells (n = 82, p = 1.4459e34; Figure 1C; Table S4).
Although 571 and 569 mRNAs were downregulated in 4EHP
null and GIGYF1/2 null cells, there was no significant overlap2 Cell Reports 33, 108262, October 13, 2020among the two datasets (n = 38, p = 0.1963; Figure S1G). Reduc-
tion of mRNA levels may be a consequence of indirect effects af-
ter the loss of these proteins.
As 4EHPandGIGYF1/2 are negative regulators ofmRNA stabil-
ity (AmayaRamirez et al., 2018; Kryszke et al., 2016; Ruscica et al.,
2019), we focused our analysis on transcripts upregulated in both
cell lines (target mRNAs). GIGYF1/2 and 4EHP target mRNAs
were overrepresented for genes encoding cell surface and extra-
cellular proteins (Figures 1D and 1E). Approximately half of the
target mRNAs code for ER, membrane, or secreted proteins (Fig-
ure 1F) that are translated at the ER (Hermesh and Jansen, 2013).
Thus, these data suggest that 4EHP-GIGYF1/2 complexes regu-
late the abundance of a subset of secretome mRNAs.
GIGYF1/2 Regulate mRNA Stability
We next determined target mRNA decay rates after transcrip-
tional arrest by actinomycin D by using northern blot or qRT-
PCR. Decay kinetics in Ctrl and GIGYF1/2 null cells fitted to an
exponential decay with a single component and R2 R 0.78 (Fig-
ure 2). We found that DBNDD2, CD109, ITPR3, and NPTX1
mRNAs were stabilized in the absence of GIGYF1/2, as the cor-
responding half-lives (t1/2) mostly doubled in these cells (Fig-
ure 2). In contrast, b-ACTIN—a non-target—was degraded simi-
larly in Ctrl and null cells (Figure 2F). Therefore, GIGYF1/2
proteins are regulators of mRNA stability, as observed in
Drosophila and human HeLa cells mainly using reporter assays
(Amaya Ramirez et al., 2018; Kryszke et al., 2016; Ruscica
et al., 2019).
Multiple GIGYF1/2 Co-factors Are Required for mRNA
Decay
To obtain insight into themolecular mechanism, we probed if the
assembly of the 4EHP-GIGYF1/2-DDX6 complex (Figure S1H)
was required for mRNA decay. We measured mRNA abundance
in GIGYF1/2 null cells upon transient co-expression of 4EHP and
wild-type (WT) or mutants of the GIGYF paralogs (Figures S1I
and S1J). In GIGYF1/2 null cells, target levels increased more
than 2-fold, but not b-ACTIN (Figures 3A, 3B, and S1K). mRNA
decay was restored when 4EHP was co-expressed with GI-
GYF1/2, but not with the mutants unable to associate with
4EHP (C*), DDX6 (DDX6*), or PPGF-containing proteins (GYF
domain mutant; GYF*) (Ash et al., 2010; Peter et al., 2017,
2019; Figures 3A, 3B, and S1K). Moreover, failure in the assem-
bly of the full complex also compromisedDBNDD2 turnover (Fig-
ure S1L). Re-expression of GIGYF1/2 alone was not sufficient to
induce mRNA decay in the null cells (data not shown), as 4EHP
and GIGYF1/2 protein stabilities are co-regulated (Figures S1A
and S1B; Morita et al., 2012).
Likewise, the levels of NPTX1, CD109, and ITPR3 in 4EHP null
cells were also at least 2-fold higher (Figure S2A). Target mRNA
decay was restored upon co-expression of the 4EHP-GIGYF1/2
complex but not when 4EHP is unable to bind to the cap (cap*)
and GIGYF1/2 (S*) (Peter et al., 2017). WT and mutant GIGYF1/
2 or 4EHP expression levels were similar and did not affect the
abundance of b-ACTIN (Figures 3B, S1K, S2A, and S2B).
These results indicate that 4EHP, DDX6, and GYF domain-
associated protein(s) bind to GIGYF1/2 to promote target
mRNA degradation.
Figure 1. The 4EHP-GIGYF1/2 Complexes Regulate mRNA Abundance
(A andB) Genome-wide analysis of changes in ribosome footprints (RFPs) andmRNA abundance inGIGYF1/2 null (KO) and 4EHP null cells relative to control (Ctrl)
cells. Logarithmic fold change in RFP (log2FC) on the vertical axis is plotted as a scatter graph against the log2FC of mRNA abundance. Each dot represents an
individual gene (n = 9,870). Red, upregulated; blue, downregulated.
(C) Venn diagram showing the number of common and unique upregulated genes in 4EHP and GIGYF1/2 KO cells (n = 82; p = 1.4459e34).
(D and E) Gene Ontology terms enriched in 4EHP-GIGYF1/2 target mRNAs. Bar graphs show –log10 q values for each of the overrepresented category. Values in
parentheses indicate the % of genes within each category.
(F) Number of 4EHP-GIGYF1/2 target mRNAs encoding endoplasmic reticulum (ER), membrane, or secreted proteins. See also Figure S1.
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OPEN ACCESSThe GYF Domain of GIGYF2 Mediates mRNA Binding
To investigate the recruitment of the complex to target mRNAs,
we performed RNA-immunoprecipitation (RNA-IP) assays and
qRT-PCR. In contrast to GFP-MBP, GFP-GIGYF2 efficientlyassociated with NPTX1, CD109, DBNDD2, and ITPR3 (Figures
3C–3F; IP graphs). GIGYF2 binding increased with the length
of the target coding sequence (CDS), as longer sequences
(CD109 and ITPR3) showed higher binding efficiencies thanCell Reports 33, 108262, October 13, 2020 3
Figure 2. GIGYF1/2 Induce mRNA Decay
(A–F) Ctrl and GIGYF1/2 KO cells were treated with actinomycin D (ActD) and harvested at the indicated time points. RNA samples were analyzed by northern
blotting (A and B) or qRT-PCR (C–F) and normalized to that of TUBB or 18S rRNA. The value at time zero (before ActD addition) was defined as 100%. Results
were plotted as a function of time. Circles represent the mean value and error bars the standard deviation (SD) (n = 3). The decay curves were fitted to an
exponential decaywith a single component (dotted lines). R2 values are indicated for each curve. The half-life of eachmRNA in Ctrl and KO cells is represented as
the mean ± SD. 18S rRNA; ethidium bromide staining shows equal loading.
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OPEN ACCESSshorter ones (NPTX1 and DBNDD2). The interaction of GIGYF2
C* and DDX6* mutants with the different transcripts was compa-
rable to WT protein. However, the association of the GIGYF2
GYF* mutant with mRNA was strongly reduced (Figures 3C–
3F; IP graphs) indicating that target recognition relies on the
GYF domain of GIGYF2. All proteins were expressed at equiva-
lent levels and did not alter mRNA steady-state levels (Figures
3C–3F, input graphs, and 3G).
Similarly, V5-SBP-4EHP bound to target mRNAs in the pres-
ence of GIGYF2 WT or DDX6*, but not MBP, GIGYF2 C*, or
GYF* (Figures S2C–S2E, pull-down graphs, and S2F). mRNA
degradation, inferred from the steady-state mRNA levels, only
occurred in cells co-expressing GIGYF2 WT (Figures S2C–
S2E, input graphs). Our results indicate that binding of 4EHP to
themRNA cap requires GIGYF2 and that recruitment of the com-
plex to the target mRNA is provided by proteins interacting with
its GYF domain.
4EHP-GIGYF1/2 Complexes Trigger Co-translational
mRNA Decay
Next, we dissected the mRNA features required for turnover. We
generated reporters containing the CDS or the 30 UTR of
DBNDD2 and LGALS3BP to express in cells. Tomeasure protein
levels, a hemagglutinin (HA) tag was inserted in frame with each
CDS (Figure 4A), whereas the 30 UTRs were preceded by Renilla
luciferase ORF (R-LUC; Figure S2G).4 Cell Reports 33, 108262, October 13, 2020DBNDD2-HA and LGALS3BP-HA protein levels were
increased in GIGYF1/2 null cells (Figures 4B–4D). The corre-
sponding transcripts were also more stable in the absence of GI-
GYF1/2 (Figures 4E, 4F, 4I, and 4J), indicating that the CDS is
sufficient to recapitulate mRNA decay. In contrast, R-LUC activ-
ity and mRNA levels of the 30 UTR reporters were similar in Ctrl
and null cells (Figures S2H–S2J). Thus, target mRNA decay is in-
dependent of the 30 UTR-associated mechanisms previously
associated with the 4EHP-GIGYF1/2 complexes (Fu et al.,
2016; Kryszke et al., 2016; Schopp et al., 2017; Tollenaere
et al., 2019).
The observation that the CDS determined GIGYF1/2-depen-
dent mRNA decay suggested that turnover occurred co-transla-
tionally. We examined the decay rate of intron-less CDS re-
porters containing a premature STOP three codons
downstream of the AUG to prevent the synthesis of an HA-
tagged protein (Figures 4A–4C). Interestingly, DBNDD2-
STOP3-HA and LGALS3BP-STOP3-HA transcripts degraded
with similar rates in Ctrl and null cells (Figures 4G–4J). Hence, GI-
GYF1/2-mediated mRNA decay requires translation of the CDS.
We then analyzed the association of GIGYF2 and targets with
ribosomes by using sucrose density gradient separation (Fig-
ure S3A). GIGYF2 and its co-factor ZNF598 were mostly
observed in the top fractions of the gradient corresponding to
free ribonucleoprotein particles (RNPs) and 40S ribosome sub-
unit (Figure S3A, lanes 1–6). However, both proteins were also
(legend on next page)






OPEN ACCESSfound in the heavy fractions of the gradient, as part of the signal
was detected in polysomes (Figure S3A, lanes 13–16). In addi-
tion, GIGYF2 WT and GYF* mutant co-purified with the ribo-
somal protein eL22L1 (Figure S3B). Consistent with the idea of
ribosome-associated decay, DBNDD2, CD109, ITPR3, and
NPTX1 were engaged in translation, as the majority of each
mRNA was associated with polysomes or 80S monosomes (Fig-
ures S3C–S3F).
We also measured the interaction of GIGYF2with mRNA in the
absence of translation. Inhibition of translation with harringtonine
or puromycin did not alter GIGYF2 expression but profoundly
reduced its binding toENO2 (Figures S3G–S3J).ENO2 is another
bona fide target transcript as decay in null cells is restored upon
re-expression of the 4EHPGIGYF2 complex (Figure S3K).
Altogether, these results suggest that GIGYF2 associates with
ribosomes to induce decay of actively translating mRNAs.Ribosome Pausing Is Evident in 4EHP and GIGYF1/2
Target mRNAs
To further investigate the details of co-translational decay by
4EHP and GIGYF1/2, we had a closer look at the ribosome foot-
print distribution along the CDS of the regulated transcripts. We
found pronounced pauses, characterized by the accumulation of
unique ribosome footprints greater than the median footprint
coverage of the gene, in several of the 4EHP and GIGYF1/2 tar-
gets (Figures 5A and S4; Table S4). There was no preference for
location or peptide motif at the pause sites but several contained
Proline (Pro) and negatively charged amino acids. Pro and acidic
residues promote slow peptide bond formation and are enriched
at ribosome pause sites (Pavlov et al., 2009; Pelechano and Ale-
puz, 2017; Schuller et al., 2017; Wohlgemuth et al., 2008).
In LARGE2, translation was stalled at a Pro-Pro-Asp (P57, P58,
D59) motif located in the N-terminal region of the protein (Fig-
ure S4A), a previously described strong pause site (Ingolia
et al., 2011; Schuller et al., 2017). LARGE2 has four predicted
isoforms with distinct N-terminal regions. With the exception of
the canonical version, all other LARGE2 isoforms lack the PPD
motif due to large N-terminal truncations or a 30-amino-acid
deletion that removes residues 30 to 59.
The translational pause present in CXCL16 at a Pro-Gly-Asn
(P45,G46,N47)motif is locatedafter a stretchof10hydrophobic res-
idues, ofwhich 9 are Leu (FiguresS4BandS4C). It contains thePG
dipeptide that is overrepresented in ribosome stall sequences in
bacteria, yeast, and humans (Doerfel et al., 2013; Manjunath
et al., 2019; Pelechano and Alepuz, 2017; Schuller et al., 2017).
Prominent examples of translation pauses were also observed
in the NCKIPSD, ENO2, IFRD2, and DBNDD2 (Figures 5A andFigure 3. GIGYF1/2 Recruit Multiple Effector Proteins to Induce mRNA
(A and B) Ctrl andGIGYF1/2 KO cells were transfected with lN-HA or lN-HA-4EHP
determined by northern blotting, normalized (Norm.) to TUBB, and set to 100% in
qRT-PCR and normalized to those of 18S rRNA. Bars represent the mean value an
mutant), GYF* (GYF domain mutant), and DDX6* (DDX6-binding mutant).
(C–F) GFP immunoprecipitation (IP) assays were performed in cells transfected wi
IP samples (12%) were quantified by qRT-PCR, normalized over GAPDH, and set
the SD (n = 3). The length of the CDS of each mRNA is indicated in nucleotides (
(G) Immunoblot depicting the expression of the immunoprecipitated proteins. In
ure S2.
6 Cell Reports 33, 108262, October 13, 2020S4D–S4F). Interestingly, several of the paused ribosomes were
also identified in ribosome run off assays, coupled with ribosome
profiling, performed in HEK293 cells treated with translational in-
hibitors (Lee et al., 2012). In ENO2, increased footprints were
observed at two AUG codons (M1 and M165) following treatment
with lactimidomycin (LTM). M165 marks the position of the ribo-
some pause observed in our profiling experiment. LTM associ-
ates with ribosomes with an empty E-site (Garreau de Loubresse
et al., 2014), a feature of initiating ribosomes or elongating ribo-
someswith impaired decoding kinetics or slow peptide bond for-
mation (Buschauer et al., 2020; Schmidt et al., 2016). As no alter-
native start sites or N-terminally truncated protein isoforms have
been described for ENO2, the LTM footprint at M165 most likely
represents a ribosome paused during elongation.
The ribosome stall observed at the Asp-Asp-Glu motif of
IFRD2 (D97, D98, E99; Figure S4F) was still present after ribosome
run off assays in harringtonine-treated cells. Harringtonine is an
A-site inhibitor (Garreau de Loubresse et al., 2014) that predom-
inantly marks ribosomes positioned at the start codon (Ingolia
et al., 2011). The footprint in the presence of harringtonine at
the DDE motif is not a translation start site. Thus, the associated
ribosome did not conclude elongation (run off) following treat-
ment with the drug. Furthermore, monosome and disome
profiling in embryonic stem cells (Tuck et al., 2020) identified in
the mouse Ifrd2 mRNA increased disome occupancy at an
equivalent position of the human transcript (Figure S4G). As dis-
omes are a sign of ribosome collision and delayed elongation,
these data confirm that stalled ribosomes accumulate at the
DDE motif of IFRD2.
The translational stall detected inDBNDD2 at the Phe-Glu-Asp
(F23, E24, D25) peptide was also observed at an equivalent posi-
tion of the transcript after ribosome run off assays (Figure 5A).
Again, the observed footprint most likely identifies a ribosome
trapped during elongation because the underlying sequence is
incompatible with a translation start site.
These findings indicate that 4EHP and GIGYF1/2 regulate
mRNAs with perturbed translation elongation.4EHP-GIGYF1/2-Dependent Decay Partially Relies on
ZNF598
The presence of ribosome stalling and collision in GIGYF1/2-
regulated transcripts suggests that decay is coupled to transla-
tion surveillance and ZNF598. We applied RNA-seq and Ribo-
seq to ZNF598 null cells (Figures S5A–S5C). In these cells, the
main changes occurred at the mRNA level, as only a minor frac-
tion of genes (n = 7; Table S1) displayed significant changes in TE
(Figures S5D and S5E). From the group of genes with increasedDecay
, GFP-MBP, and GFP-GIGYF1/2 (WT ormutants).DBNDD2mRNA levels were
Ctrl cells.NPTX1,CD109, ITPR3, and b-ACTINmRNA levels were quantified by
d error bars the SD (n = 3). GIGYF1/2 mutants are as follows: C* (4EHP-binding
th GFP-MBP or GFP-GIGYF2 (WT or mutants). mRNA levels in input (0.8%) and
to 100% in the presence of MBP. Bars indicate the mean value and error bars
nt).
puts and immunoprecipitates were 2% and 2.7%, respectively. See also Fig-
(legend on next page)






OPEN ACCESSmRNA abundance in the null cells (n = 357), 9.2% and 14%were
also upregulated in the absence of GIGYF1/2 (p = 3.089792e8)
or 4EHP (p = 2.37387e12), respectively (Figure S5F; Table S6).
4EHP, GIGYF1/2, and ZNF598 commonly upregulated tran-
scripts (n = 6), included ENO2 andCXCL16, which display prom-
inent ribosome pauses (Figures S4B and S4E). Increased tran-
script levels were the result of enhanced mRNA stability as the
t1/2 of ENO2 and CXCL16 increased in the absence of ZNF598
(Figures S5G and S5H). Thus, co-translational decay of a subset
of 4EHP and GIGYF1/2 targets is dependent on ZNF598.Ribosome Pausing Initiates 4EHP-GIGYF1/2-Dependent
mRNA Decay
To confirm that ribosome pausing in GIGYF1/2 and 4EHP targets
induces mRNA decay, we investigated the significance of the
translational stall present in DBNDD2. We introduced a prema-
ture STOP before the pause site in the DBNDD2-HA reporter
(STOP18; Figure 5B) andmeasured mRNA levels in cells. Consis-
tent with a failure to degrade mRNA in the absence of the trans-
lational pause, DBNDD2-STOP18-HA levels did not vary in cells
lacking GIGYF1/2 (Figures 5C and 5D).
DBNDD2 is a Pro-rich protein with two Pro tripeptides (P46,
P47, P48 and P85, P86, P87). Although we have not observed ribo-
some stalling at these positions, poly-Pro motifs are known to
interfere with elongation (Gardin et al., 2014; Gutierrez et al.,
2013; Ingolia et al., 2011; Pavlov et al., 2009; Wohlgemuth
et al., 2008). We generated reporters with STOPs that prevented
(STOP39 and STOP79) or allowed (STOP89) the translation of the
poly-Pro sequences by the ribosome (Figure 5B). As observed
forWTDBNDD2-HA, the abundance of the reporters with STOPs
after the FEDmotif was regulated by the 4EHP-GIGYF2 complex
(Figures 5B–5D). Thus, only the identified ribosome pause is
required for GIGYF1/2-dependent degradation of the
DBNDD2-HA mRNA. All the premature STOPs blocked the syn-
thesis of HA-tagged proteins (Figure 5C) and did not significantly
alter the expression of the different reporters (Figure S6A).
Because the degradation efficiency of nonsense-mediated
decay (NMD) substrates in HEK293 cells is low (Gerbracht
et al., 2017), the abundance of DBNDD2-STOP18-HA was unal-
tered in UPF1-depleted cells (Figures S6B and S6C).
To test if impaired decoding or slow peptide bond formation at
the pause site results in destabilization of DBNDD2, we
substituted the FED motif by triple alanine (Figure 5B). However,
the levels of the DBNDD2-FED25-AAA-HA protein still responded
to variations in GIGYF1/2 levels (Figure S6D). These data indi-
cate that although the ribosome is paused at the FED motif (Fig-
ure 5A), translational pausing and subsequent mRNA turnover
must be caused by another mechanism. As in the case of tubulin
autoregulation (Lin et al., 2020), we explored the possibility thatFigure 4. GIGYF1/2 Mediates Co-translational mRNA Decay
(A) Schematic representation of the DBNDD2-HA and LGALS3BP-HA CDS repo
three codons downstream of AUG; SP, signal peptide.
(B–D) Ctrl and GIGYF1/2 KO cells were transfected with DBNDD2-HA or LGALS
western blotting using anti-HA and anti-GFP antibodies. (D) DBNDD2-HA protein le
in Ctrl cells. Bars indicate the mean value, and error bars indicate the SD (n=3).
(E–J) Cells were transfectedwithDBNDD2-HA (E andG) or LGALS3BP-HA (F and
(E–H) Show representative northern blots. (I and J) mRNA levels were quantified
8 Cell Reports 33, 108262, October 13, 2020mRNA stability was controlled by factors that recognize the
nascent chain and interfere with elongation.We altered the N ter-
minus of DBNDD2 (M1AAA instead of M1DPN) and assessed re-
porter mRNA and protein levels. In Ctrl cells, DBNDD2-DPN4-
AAA-HA mRNA was better expressed and more stable than
the WT reporter (Figures 5E and 5F). Moreover, its protein levels
were not regulated by GIGYF1/2 (Figure S6D). These results
show that the first translated codons of DBNDD2-HA are
required for decay in a GIGYF1/2-dependent manner. One plau-
sible explanation is that factors binding to the emergent nascent
chain modulate ribosome occupancy, cause ribosome pausing,
and promote GIGYF1/2-dependent destabilization of the tran-
script. In this scenario, the ribosome pauses at a location in
the mRNA reflecting the distance traveled by the nascent chain
inside the ribosome tunnel.GIGYF1/2-Dependent mRNA Decay Can Occur during
Co-translational ER Targeting
Many of the 4EHP-GIGYF1/2 target mRNAs encode signal pep-
tide (SP)-containing proteins (Figure 1F) that undergo SRP-
dependent translocation to the ER. Binding of SRP to the SP
transiently interferes with translation elongation and leads to
stacking and ribosome collision at the 50 end of the CDS (Arpat
et al., 2020; Walter and Blobel, 1981; Wolin and Walter, 1988,
1989).
To study if translational pausing associated with ER targeting
is linked to GIGYF1/2-mediated mRNA decay, we made use of
the LGALS3BP-HA reporter. LGALS3BP is a secreted protein
containing a SP with 18 amino acids in length. Consistent with
translational pausing during targeting to the ER, ribosome foot-
prints are detected downstream of the signal sequence (Asp21)
in run off assays performed in cells treated with harringtonine
and LTM (Lee et al., 2012). Likewise, a disome peak is observed
at Val60 (Han et al., 2020; Figure 6A).
We introduced STOP codons 30 and 60 residues after the initi-
ating AUG to prevent (STOP30) or allow (STOP60) the exposure of
the SP from the ribosome tunnel and the targeting of the mRNA
to the ER (Figure 6B; Jan et al., 2014; Kowarik et al., 2002). The
premature STOPs did not reduce transcript expression (Fig-
ure S6E) or trigger NMD, as LGALS3BP-STOP30-HA mRNA
levels remain the same in the presence (scramble short hairpin
RNA [shRNA]) or absence of UPF1 (UPF1 shRNA; Figure S6F).
We observed that LGALS3BP-HA and LGALS3BP-STOP60-
HA mRNA levels increased in the absence of GIGYF1/2 and
decreased upon re-expression of 4EHP and GIGYF2 (Figures
6C and 6D). In contrast, LGALS3BP-STOP30-HA was more
abundant in Ctrl cells, and its levels did not respond to changes
in GIGYF1/2 expression (Figures 6C, 6D, and S6E). Our results
indicate that GIGYF1/2-dependent mRNA decay requires therters. ORF, open reading frame; HA, hemagglutinin; STOP3, STOP positioned
3BP-HA (WT or STOP3) and F-LUC-GFP. Protein samples were analyzed by
vels were quantified, normalized over to those of F-LUC-GFP, and set to 100%
H) (WT or STOP3), treated with ActD, and harvested at the indicated time points.
, as described in Figure 2A. See also Figure S2.
Figure 5. Ribosome Pausing Triggers GIGYF1/2-Dependent mRNA Decay
(A) RFP profiles of DBNDD2 in Ctrl, GIGYF1/2 KO, and cells treated with harringtonine and lactimidomycin (LTM) (Lee et al., 2012). Dashed blue box highlights
ribosome pausing. Gene annotation, protein sequence, and residue numbering are depicted below the profiles. M1, Met1.
(B) Schematic representation of the DBNDD2-HA reporters. Pause23, position of the stall peptide (FED25); PPP48 and PPP87, poly-Pro motifs. STOPs were
introduced 18, 39, 79, and 89 codons after the AUG. Alanine substitutions were inserted at the stall site and at the N terminus of the protein (DPN4).
(C and D) Ctrl and GIGYF1/2 KO cells were transfected withDBNDD2-HA (WT or STOPs) and F-LUC-GFP. Cells were also co-transfected with GFP-MBP or GFP-
GIGYF2 and V5-SBP-4EHP. mRNA levels were determined by northern blotting (C), normalized to F-LUC-GFP, and set to 100% in Ctrl cells (D). Bars indicate the
mean value and error bars the SD (n = 3). The immunoblot with the expression of the GFP-, HA-, and V5-tagged proteins is also shown.
(E) Cells were transfected with DBNDD2-HA (WT or DPN4-AAA). Reporter mRNA levels were quantified by qRT-PCR, normalized over to those of 18S rRNA, and
set to 100% for DBNDD2-HA WT. Bars indicate the mean value and error bars the SD (n = 3).
(F) Cells transfected with DBNDD2-HA (WT or DPN4-AAA) were treated with ActD and harvested at the indicated time points. mRNA levels were quantified by
qRT-PCR as described in Figure 2A. See also Figures S4 and S6.
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OPEN ACCESSsynthesis of the SP and co-translational ER targeting of
LGALS3BP-HA.
GIGYF2 also efficiently associated with the LGALS3BP-HA
mRNA (Figures 6E and 6F). Binding to the mRNA was greatlyimpaired if a STOP codon was present at the beginning of the
CDS (STOP3) to prevent the synthesis and exposure of the SP
(Figures 4A and 6F). These results suggest that GIGYF2 interacts
with translating LGALS3BP mRNA.Cell Reports 33, 108262, October 13, 2020 9
Figure 6. GIGYF1/2 Induce Co-translational Decay of Secretome mRNAs
(A) RFP profiles for LGALS3BP in Ctrl and GIGYF1/2 KO cells and in the presence of harringtonine or LTM (Lee et al., 2012). Disome occurrence along the CDS
(Han et al., 2020) is also shown. Gene annotation is depicted below the profiles. M1, Met1; D21, Asp21; V60, Val60; uORF, upstream ORF.
(B) Schematic representation of the LGALS3BP-HA and R-LUC reporters. STOPs were introduced 30 and 60 codons after the AUG in LGALS3BP-HA. The signal
sequences of the LGALS3BP and NPTX1 SPs were inserted upstream and in frame with the R-LUC CDS.
(C) LGALS3BP-HA (WT and STOPs) mRNA levels were measured by qRT-PCR in samples obtained from cells co-transfected with F-LUC-GFP, GFP-MBP, or GFP-
GIGYF2, andlN-HA-4EHP.mRNA levelswere set to100%inCtrl cells after normalization toF-LUC-GFP. Bars indicate themeanvalue; errorbars representSD (n=3).
(legend continued on next page)
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induce GIGYF1/2-dependent co-translational mRNA decay.
We transfected cells with chimeric reporters in which R-LUC is
in frame with the SP sequences of LGALS3BP or NPTX1 (Fig-
ure 6B). In comparison, the abundance of SPLGALS3BP-R-LUC
and SPNPTX1-R-LUC mRNAs increased in GIGYF1/2 null cells
(Figures 6G, lanes 5 and 8, and 6H). Re-expression of GIGYF2
and 4EHP was sufficient to decrease transcript levels in the
null cells (Figures 6G, lanes 6 and 9, and 6H). In contrast, R-
LUC abundance did not vary in the absence of GIGYF1/2 (Fig-
ures 6G, lanes 1–3, and 6H).
Collectively, these data support a model in which binding of
GIGYF1/2 to a subset of secretome transcripts induces co-
translational mRNA turnover. GIGYF1/2-mediated mRNA degra-
dation ismost likely favored by changes in elongation during syn-
thesis of the SP.
Tubulin mRNAs Are Regulated by GIGYF1/2
Tubulin mRNAs are co-translationally degraded in cells with
excess soluble subunits (Cleveland et al., 1981; Lin et al.,
2020). TUBA4A and TUBB4A are 4EHP and GIGYF1/2 target
mRNAs (Tables S2, S3, and S4). Using qRT-PCR, we confirmed
that TUBA4A and TUBB4A abundance, but not TUBB, increased
in GIGYF1/2 null cells (Figures 7A–7C). Consistent with a role of
the complex in tubulin mRNA degradation, selective reduction of
TUBA4A and TUBB4A levels was achieved in the null cells by re-
expression of 4EHP and GIGYF2 (Figures 7A and 7B). Further-
more, TUBA4A was efficiently bound by GIGYF2 in a GYF-
domain-dependent manner (Figure 7D).
Next, we examined if GIGYF1/2 regulate mRNA abundance in
response to the level of free tubulin subunits. Pre-treatment of
Ctrl cells with themicrotubule destabilizing agent nocodazole eli-
cited the decay of several tubulinmRNAs, as their levels dropped
considerably (60%–75%) (Figures 7E–7I). In the absence of GI-
GYF1/2, nocodazole-induced decay only reduced mRNA levels
by 35%–50% (Figures 7E–7I), suggesting that GIGYF1/2 may
contribute to tubulin autoregulation. However, as 4EHP and GI-
GYF1/2 regulate mRNA turnover also in the absence of nocoda-
zole (Figures 7A and 7B), further studies are required to address
their effect in the control of tubulin levels in cells.
While tubulin autoregulation occurs co-translationally (Gay
et al., 1989; Pachter et al., 1987), it remains unclear if the under-
lying mechanism is coupled with translational surveillance. Con-
ventional ribosome profiling does not uncover ribosome pausing
in tubulin mRNAs (Figures 7J and 7K). However, an analysis of
ribosome footprints following run off assays (Lee et al., 2012)
and disome profiling (Han et al., 2020; Tuck et al., 2020) shows
that stalling and collision are frequent in TUBA4A, TUBA1A,
and TUBA1B (Figures 7J, 7K, and S7A–S7D). Interestingly, the(D) Analysis of GFP and HA protein expression by immunoblotting.
(E and F) The interaction of GFP-GIGYF2 with LGALS3BP-HAmRNA was analyze
control. Input (0.2% for the GFP proteins and 0.7% for LGALS3BP-HA) and immun
were analyzed by western blotting with anti-GFP antibodies. In (F), LGALS3BP-H
quantified by qRT-PCR, normalized to GAPDH, and set to 100% in the presence
(G and H) R-LUC, SPLGALS3BP-R-LUC, or SPNPTX1-R-LUC mRNAs were quantifie
GYF2, and lN-HA-4EHP. NormalizedmRNA levels were set to 100% in Ctrl cells. B
GFP- and HA-tagged proteins was assessed by immunoblotting and is shown bstalled and collided ribosomes are positioned 20 to 30 amino
acids after the N-terminal motif of tubulins with a critical role in
autoregulation (Figures 7J, 7K, and S7A–S7D; Pachter et al.,
1987; Yen et al., 1988). Based on the 35-residue length of the
exit tunnel, the N-termini of tubulins would start to emerge
from the ribosome. These observations suggest that 4EHP and
GIGYF1/2 trigger the decay of tubulin mRNAs with perturbed
translation elongation.
Collectively, our work shows that recognition of the nascent
peptide by surveillance factors and detection of ribosome
pausing and collisions during translation trigger GIGYF1/2-
dependent mRNA decay (Figure S7E).
DISCUSSION
This study shows that 4EHP and GIGYF1/2 are selective regula-
tors of mRNA turnover. Targeted transcripts frequently encode
membrane-bound and secreted proteins, implicating 4EHP
andGIGYF1/2 in the regulation of a subset of secretomemRNAs.
Degradation is coupled with translation and is triggered by
changes in ribosome activity during elongation. This function ex-
pands the role of the complex as a regulator of gene expression
beyond the 30 UTR-directed mechanisms operating during
inflammation or miRNA-mediated gene silencing (Fu et al.,
2016; Schopp et al., 2017; Tollenaere et al., 2019). Our findings
have multiple implications for both translational control and
mRNA decay and open future research directions.
Co-translational mRNA Decay by GIGYF1/2 Proteins
We find that co-translational mRNA degradation requires the co-
ordinated action of several GIGYF1/2 co-factors. Binding and
mRNA selection rely on GYF domain interacting proteins, such
as ZNF598 that recruits 4EHP and GIGYF1/2 to destabilize tran-
scripts marked by ribosome collisions. An alternate mode of se-
lection relies on the recruitment of GIGYF1/2 by translation sur-
veillance factors that recognize the nascent peptide as it
emerges from the ribosome exit tunnel. Future studies will iden-
tify the surveillance factors synchronizing the recognition of the
nascent chain with altered ribosome activity and the recruitment
of the 4EHP-GIGYF1/2 complexes. The diversity of mechanisms
for target recognition centralized on GIGYF1/2 proteins opens
the possibility that mRNA decay is subject to regulation.
GIGYF1/2-directed recruitment of 4EHP to the cap not only re-
duces translation initiation but also facilitates the activity of the
decay machinery. The reduced cap affinity of 4EHP compared
with that of eIF4E (Chapat et al., 2017; Peter et al., 2017; Rom
et al., 1998; Zuberek et al., 2007) exposes the mRNA to decapp-
ing (Ruscica et al., 2019). A scenario in which the recruitment of
deadenylation and decapping factors by GIGYF1/2 occurs co-d in coIP assays by using anti-GFP antibodies. GFP-MBP served as a negative
oprecipitated fractions (2.7% for the GFP proteins and 5% for LGALS3BP-HA)
A (WT or STOP3) mRNA abundance in input (0.8%) and IP samples (12%) was
of MBP. Bars represent the mean value and error bars the SD (n = 3).
d by northern blotting in cells expressing F-LUC-GFP, GFP-MBP or GFP-GI-
ars indicate themean value and error bars the SD (n = 3). The expression of the
elow the northern blot.
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Figure 7. GIGYF1/2 Participate in Tubulin Co-translational mRNA Decay
(A–C) Cells were transfected with GFP-MBP or GFP-GIGYF2 and lN-HA-4EHP. Tubulin mRNA levels were quantified by qRT-PCR, normalized to those of 18S
rRNA (A and B) or GAPDH mRNA (C), and set to 100% in Ctrl cells. Plotted is the mean ± SD (n = 3).
(legend continued on next page)






OPEN ACCESStranslationally is in agreement with the ribosomal association
and activity of decay factors, such as DDX6 (Sweet et al.,
2012), the CCR4-NOT complex (Buschauer et al., 2020), and
XRN1 (Pelechano et al., 2015; Tesina et al., 2019; Tuck et al.,
2020), and would irreversibly prevent the translation of tran-
scripts with impaired elongation.
Our data further support a role for DDX6 in GIGYF1/2-depen-
dent mRNA decay and suggest that this RNA helicasemight also
monitor ribosome speed in the targeted transcripts, as demon-
strated for mRNAs with poor codon optimality (Radhakrishnan
et al., 2016).
GIGYF1/2 Mediate mRNA Decay in Response to
Disturbed Elongation
Here, we present evidence that perturbed ribosome dynamics
during elongation triggers canonical mRNA degradation by GI-
GYF1/2. Ribosome pausing and queuing prevailed in 4EHP
and GIGYF1/2 target mRNAs. Pause sites included known stall-
ing sequences and were associated with factors recognizing the
nascent peptide. Co-translational target mRNA decay was in
part mediated by ZNF598, a sensor of ribosome collisions, and
in the absence of ribosome stalling, the abundance of target-
based reporter transcripts was no longer regulated by GIGYF1/
2. In addition, degradation of some of the GIGYF1/2 targets,
such as tubulins and secretome mRNAs, is known to be depen-
dent on translation and ribosome-associated factors (Cleveland
et al., 1981; Karamyshev et al., 2014; Lakshminarayan et al.,
2020; Lin et al., 2020).
Our findings suggest a model for which selective recruitment
of 4EHP and GIGYF1/2 to mRNAs with altered elongation pro-
motes translation repression and mRNA degradation. Target
selection involves the recognition of stalled ribosomes by
specialized co-factors and/or of the nascent peptide by surveil-
lance proteins (Figure S7E). In line with the recruitment of 4EHP
and GIGYF1/2 to mRNAs with failed translation events, while
our work was under review, different studies revealed that ribo-
some collisions trigger the inhibition of translation initiation by
4EHP and GIGYF2 (Hickey et al., 2020; Juszkiewicz et al.,
2020; Sinha et al., 2020). In this context, EDF1 (endothelial dif-
ferentiation-related factor 1) facilitates the recruitment of
4EHP-GIGYF2 to the stalled ribosomes (Juszkiewicz et al.,
2020; Sinha et al., 2020). Additional studies are warranted to
understand the contribution of EDF1 to 4EHP- and GIGYF1/2-
dependent co-translational mRNA decay.
GIGYF1/2 and Disease
Translation-dependent canonical mRNA degradation has been
implicated in different cellular events. Autoregulation of tubulin
mRNA abundance is crucial for proper cell division (Lin et al.,(D) GIGYF2 binding to TUBA4A mRNA was determined by RNA-IP, as described
(E–I) Cells were treated with either DMSO () or nocodazole (+) for 3 h. Tubulin mR
100% in the absence of nocodazole. Plotted is the mean ± SD (n = 3). Brackets i
treatment.
(J and K) RFP profiles of TUBA4A and TUBA1A in Ctrl, GIGYF1/2 KO, and cells trea
the distribution of disome footprints along the CDS (Han et al., 2020). Dashed
horizontal lines indicate footprint peaks that result from non-unique reads with nuc
not considered as ribosome pauses. M1, Met1; W21, Trp21; R2, Arg2; E, Glu; C, C2020). Moreover, mutations in the autoregulatory domain of
TUBB4A that abolish translation-coupled mRNA decay have
been described in hereditary dystonia (Hersheson et al., 2013).
As shown in this work, 4EHP and GIGYF1/2 participate in the
turnover of different tubulin mRNAs. Additional studies are now
required to identify the precise mechanism that links the recruit-
ment of the 4EHP-GIGYF1/2 complex and the binding of TTC5 to
the tubulin nascent peptide when cells activate autoregulation
(Lin et al., 2020). Furthermore, our findings suggest that in the
absence of GIGYF1/2, cells might be more prone to defects in
division.
Co-translational mRNA decay likewise guarantees the quality
of secretory and membrane proteins. To reduce the accumula-
tion of misfolded and potentially toxic proteins, failure in protein
targeting to the ER elicits degradation of the ribosome-bound
message (Karamyshev et al., 2014; Lakshminarayan et al.,
2020; Pinarbasi et al., 2018). Here, we identified the 4EHP-GI-
GYF1/2 complex as a member of the quality control system
that regulates the turnover of a subset of secretome-associated
mRNAs during co-translational assembly in the ER. We pro-
pose that 4EHP and GIGYF1/2 could likewise be important to
trigger the degradation of specific mRNAs when the SP has
reduced ability for ER targeting or folding. Given its ability to
associate with polysomes and ribosomal proteins, one possi-
bility is that like SRP (Voorhees and Hegde, 2015), GIGYF1/2
is co-translationally recruited at the initial stages of protein syn-
thesis, scanning translating ribosomes as the SP elongates
through the exit tunnel and interferes with the translation cycle.
If ER targeting fails, GIGYF1/2 are then posed to elicit decay of
the translating mRNA, avoiding the accumulation of misfolded
proteins.
Although the causal mechanisms remain unknown, GIGYF1/2
loss and haploinsufficiency are associated with neurodegenera-
tion and neurological disorders in animal models and affected hu-
mans (Giovannone et al., 2009; Iossifov et al., 2014; Krumm et al.,
2015; Satterstrom et al., 2020; Schizophrenia Working Group of
the Psychiatric Genomics Consortium, 2014; Thyme et al.,
2019). Our work reports a previously unappreciated role of GI-
GYF1/2 in safeguarding the integrity of the proteome by signaling
to conventional decaymRNAswith altered ribosomeprogression.
This function of GIGYF1/2 proteins prevents the synthesis of un-
wanted or potentially cytotoxic proteins and, if compromised,
may contribute to the development of neurological diseases.
Limitations
Our work highlights 4EHP and GIGYF1/2 as regulators of co-
translational mRNA decay. To extend our observations to dis-
ease-related contexts, identification of the transcripts and ribo-
some-associated mechanisms regulated by 4EHP andin Figure 3.
NA abundance was quantified by qRT-PCR, normalized toGAPDH, and set to
ndicate the approximate reduction in mRNA abundance following nocodazole
tedwith harringtonine or LTM (Lee et al., 2012). The TUBA1A profile also shows
squares identify paused ribosomes and disomes. In TUBA4A RFP, the black
leotide sequences common tomultiple tubulin subunits. These footprints were
ys; Y24, Tyr24. See also Figure S7.
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related stress is still necessary. Such studies will greatly increase
our knowledge on how translation-coupled mRNA decay tunes
the cellular proteome.STAR+METHODS
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Räsch, F., Weber, R., Izaurralde, E., and Igreja, C. (2020). 4E-T-bound mRNAs
are stored in a silenced and deadenylated form. Genes Dev. 34, 847–860.
Robinson, M.D., McCarthy, D.J., and Smyth, G.K. (2010). edgeR: a Bio-
conductor package for differential expression analysis of digital gene expres-
sion data. Bioinformatics 26, 139–140.
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P:C:I, stabilized PanReac AppliChem Cat. #A0889,0100
RiboLock Thermo Scientific Cat. #EO0381
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Nitrocellulose Transfer Membrane Santa Cruz Biotechnology Cat. #sc-3724
Luminol Roth Cat. #4203.1
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Cycloheximide Serva Electrophoresis Cat. #10700
Nocodazole Sigma Aldrich Cat #M1404
TurboDNase Thermo Scientific Cat. #AM2238
RNA Clean & Concentrator Kit Zymo Research Cat. #R1015
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Zymoclean Gel DNA Recovery Kit Zymo Research Cat. #D4007
MicroSpin S-400 HR Columns GE Healthcare Cat. #27514001
RNaseI Thermo Scientific Cat. #AM2294
SUPERase Inhibitor Thermo Scientific Cat. #AM2694
Ribo-Zero Gold rRNA Removal Kit Illumina discontinued
SYBR Gold Thermo Scientific Cat. #S11494
SuperScript II reverse transcriptase Thermo Scientific Cat. #18064014
SuperScript III reverse transcriptase Thermo Scientific Cat. #18080044
T4 Polynucleotide kinase NEB Cat. #M0201S
GlycoBlue Thermo Scientific Cat. #AM9515
T4 RNA Ligase 2, truncated K227Q NEB Cat. #M0351S
50 DNA Adenylation Kit NEB Cat. #E2610S
T4 RNA Ligase 1 NEB Cat. #M0204S
Critical Commercial Assays
RNeasy Mini Kit QIAGEN Cat. #74104
Dual-luciferase reporter assay Promega Cat. #E1960
iTaq Sybr Green Supermix Biorad Cat. #170-8885
Wizard SV Genomic DNA Purification
System
Promega Cat. #A2360
TruSeq RNA sample Prep Kit Illumina Cat. #RS-122-2002
Deposited Data
Raw and analyzed RNA-Seq and Ribo-Seq
data – WT, 4EHP-null and GIGYF1/2-null
HEK293T cells
This study GEO: GSE144841
Raw and analyzed RNA-Seq and Ribo-Seq
data – WT and ZNF598-null HEK293T cells
This study GSE149279
Harringtonine and LTM treated HEK293
cells
Lee et al., 2012 SRA: SRA056377
Monosome and disome profiling of HEK293
cells
Han et al., 2020 GEO: GSE145723
Monosome and disome profiling in mESCs Tuck et al., 2020 GEO: GSE134020
Source imaging data This study – Mendeley data https://doi.org/10.17632/dk55r385cj.1
Experimental Models: Cell Lines
HEK293T DSMZ ACC 635
GIGYF1/2 KO Peter et al., 2017 N/A
4EHP KO Räsch et al., 2020 N/A
ZNF598 KO This study N/A
Oligonucleotides
Oligonucleotides, see Table S7 This study N/A
Recombinant DNA
plN-HA-C1-HseIF4E2 (4EHP) Peter et al., 2017 Uniprot: O60573-1
plN-HA-C1-HseIF4E2 W124A (cap*) Peter et al., 2017 N/A
plN-HA-C1-HseIF4E2 R103L, E149L (S*) Peter et al., 2017 N/A
pT7-V5-SBP-C1-HseIF4E2 (4EHP) Peter et al., 2017 N/A
pT7-V5-SBP- C1-HseIF4E2 W124A (cap*) Peter et al., 2017 N/A
pT7-V5-SBP- C1-HseIF4E2 R103L, E149L
(S*)
Peter et al., 2017 N/A
pT7-EGFP-C1-HsGIGYF1 Peter et al., 2017 Uniprot: O60573-1
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pT7-EGFP-C1-HsGIGYF1 Y39A Y41A
M46A L47A (C*)
Peter et al., 2017 N/A
pT7-EGFP-C1-HsGIGYF1 Y479A F490A
W498A F504A (GYF*)
Peter et al., 2017 N/A
pT7-EGFP-C1-HsGIGYF1 W294A, F306A,
F312A (DDX6*)
Peter et al., 2019 N/A
pT7-EGFP-C1-HsGIGYF2 Peter et al., 2017 Uniprot: Q6Y7W6-1
pT7-EGFP-C1-HsGIGYF2 Y41A Y43A
M48A L49A (C*)
Peter et al., 2017 N/A
pT7-EGFP-C1-HsGIGYF2 Y538A, F549A,
W557A, F563A (GYF*)
Peter et al., 2017 N/A
pT7-EGFP-C1-HsGIGYF2 W288A, F300A,
F306A (DDX6*)




pEGFP-N3-F-Luc-EGFP Lazzaretti et al., 2009 N/A
pCIneo-HsDBNDD2-HA This study Uniprot: Q9BQY9-2
pCIneo-HsDBNDD2-STOP3-HA This study N/A
pCIneo-HsDBNDD2-STOP18-HA This study N/A
pCIneo-HsDBNDD2-STOP39-HA This study N/A
pCIneo-HsDBNDD2-STOP79-HA This study N/A
pCIneo-HsDBNDD2-STOP89-HA This study N/A
pCIneo-HsDBNDD2-FED25-AAA-HA This study N/A
pCIneo-HsDBNDD2-DPN4-AAA-HA This study N/A
pCIneo-R-Luc-HsDBNDD2 30 UTR This study N/A
pCIneo-HsLGALS3BP-HA This study Uniprot: Q08380-1
pCIneo-HsLGALS3BP-STOP3-HA This study N/A
pCIneo-HsLGALS3BP-STOP30-HA This study N/A
pCIneo-HsLGALS3BP-STOP60-HA This study N/A
pCIneo-R-LUC-HsLGALS3BP 30 UTR This study N/A
pCIneo-Hs SPLGALS3BP-R-LUC This study N/A
pCIneo-Hs SPNPTX1-R-LUC This study N/A
pCIneo-R-LUC Pillai et al., 2004 N/A
pSpCas9(BB)-2A-Puro (PX459) Ran et al., 2013 Addgene 48139
pSUPERpuro-BglII-scrambled Jonas et al., 2013 N/A
pSUPERpuro-BglII-HsUPF1-t2 Paillusson et al., 2005 N/A
pSUPERpuro-BglII-HsUPF1-t4 Paillusson et al., 2005 N/A
Software and Algorithms
Adobe Illustrator Adobe https://www.adobe.com/uk/creativecloud.
html




ImageJ Schneider et al., 2012 https://imagej.nih.gov/ij/
Bowtie 2 Langmead and Salzberg, 2012 http://bowtie-bio.sourceforge.net/bowtie2/
index.shtml
TopHat 2 Kim et al., 2013 https://ccb.jhu.edu/software/tophat/index.
shtml
RiboTaper Calviello et al., 2016 https://ohlerlab.mdc-berlin.de/software/
RiboTaper_126/
(Continued on next page)





REAGENT or RESOURCE SOURCE IDENTIFIER
QuasR Gaidatzis et al., 2015 https://bioconductor.org/packages/
release/bioc/html/QuasR.html
edgeR McCarthy et al., 2012; Robinson et al., 2010 https://bioconductor.org/packages/
release/bioc/html/edgeR.html
RiboDiff Zhong et al., 2017 https://github.com/ratschlab/RiboDiff
goseq Young et al., 2010 https://bioconductor.org/packages/
release/bioc/html/goseq.html







Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Catia
Igreja (catia.igreja@tuebingen.mpg.de).
Materials Availability
All unique/stable reagents generated in this study are available from the Lead Contact with a completed Materials Transfer
Agreement.
Data and Code Availability
The accession numbers for the RNA-seq and Ribo-seq data in WT, 4EHP-null, GIGYF1/2-null and ZNF598-null HEK293T cells re-
ported in this paper are Gene Expression Omnibus (GEO): GSE144841 and GSE149279). Original data have been deposited to Men-
deley Data: https://doi.org/10.17632/dk55r385cj.1.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines
All cell lines were cultured at 37Cand 5%CO2 in Dulbecco’sModified Eagle’sMedium (DMEM) supplementedwith 10% fetal bovine
serum, 2 mM Glutamine, 1x Penicillin and 1x Streptomycin.
METHOD DETAILS
DNA constructs
DNA constructs used in this study are listed in the Key Resources Table. All plasmids used in the assays depicted in Figures 3 and S2,
the Renilla luciferase (R-LUC) and the firefly luciferase (F-LUC)-EGFP reporters were described previously (Lazzaretti et al., 2009;
Peter et al., 2017; Pillai et al., 2004). The UPF1 shRNA plasmids were a kind gift from Oliver M€uhlemann (Paillusson et al., 2005).
To generate the CDS reporters, the sequences of DBNDD2 or the LGALS3BP ORFs were cloned into the NheI-XbaI restriction sites
of the pCIneo vector. The C-terminal HA-tag was inserted by site-directed mutagenesis. TheDBNDD2-STOP-HA reporters with UAA
stop codons at various positions (3, 18, 39, 79 and 89 codons downstream of the AUG start site) and the LGALS3BP-STOP-HA re-
porters with UAA stop codons at various positions (3, 30 and 60 codons downstream of the AUG start site) were generated by muta-
genesis. To obtain the 30 UTR reporters, the sequences of DBNDD2 or the LGALS3BP 30 UTRs were cloned into the XhoI-NotI and
XbaI-NotI restriction sites of the pCIneo-R-LUC vector, respectively. The eL22L1 (1-122) was cloned into the NheI-XbaI restriction
sites of the pCIneo vector; the N-terminal V5-SBP sequence was inserted by mutagenesis. To generate the SP-R-LUC vectors
the sequences corresponding to the signal peptides (as annotated by Uniprot) of LGALS3BP (1-18: MTPPRLFWVWLLVAGTQG)
and NPTX1 (1-22: MPAGRAARTCALLALCLLGAGA) were cloned upstream of R-LUC ORF in the pCIneo-R-LUC vector by mutagen-
esis. All the mutants used in this study were generated by site-directed mutagenesis using the QuickChange Site-DirectedMutagen-
esis kit (Stratagene). All the constructs were confirmed by sequencing.
Generation of the 4EHP null and ZNF598 null cell lines
sgRNAs targeting 4EHP and ZNF598 were designed using the CHOPCHOP (http://chopchop.cbu.uib.no) online tool (Labun et al.,
2016, 2019; Montague et al., 2014) and cloned into the pSpCas9(BB)-2A-Puro (PX459) vector [a gift from F. Zhang, Addgene plasmid
48139; (Ran et al., 2013)]. Clonal cell lines were obtained and confirmed for gene editing as described previously (Peter et al., 2017).Cell Reports 33, 108262, October 13, 2020 e4
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OPEN ACCESSBriefly, HEK293T cells were transfectedwith the sgRNA-Cas9 vectors. Two days post transfection, cells were treatedwith puromycin
(3 mg/ml; Serva Electrophoresis) to select for edited cells. Serial dilutions in 96-well plates were used to obtain single cell clones.
Genomic DNA was isolated from single clones using the Wizard SV Genomic DNA Purification System (Promega). The 4EHP locus
was PCR amplified and Sanger sequencing of the targeted genomic regions confirmed two frameshift mutations in exon 4 (an 11
nucleotide and a 37 nucleotide deletions) targeted by sg4EHP-a. For sg4EHP-b we did not observe gene editing; the amplified
sequence around the target site in exon 2 is wild-type. The ZNF598 locus was targeted by sgZNF598-a (exon 3) and sgZNF598-b
(exon 4). RNA sequencing shows that in ZNF598 KO cells genome editing resulted in the expression of a ZNF598 transcript that lacks
exons 1-4 and retains intron 4 at the 50 end. This transcript has reduced translation efficiency and is subject to degradation. The lack
of 4EHP and ZNF598 expression was confirmed by western blotting (Figures S1A and S5A). See Table S7 for sgRNA sequences.
Ribosome profiling and RNA sequencing
HEK293T (DSMZ, ACC 635) wild-type, GIGYF1/2 null (Peter et al., 2017), 4EHP null (Räsch et al., 2020) and ZNF598 null cells were
plated on 10 cm dishes 24 hours before harvesting, as previously described (Calviello et al., 2016). Cells were lysed with lysis buffer
(20 mM Tris-HCl pH = 7.4, 150 mMNaCl, 5 mMMgCl2, 1 mMDTT, 1% Triton X-100, 0.5% NP40) containing cyclohexamide (100 mg/
ml). Lysates were then used for total RNA extraction and ribosome profiling (1/4 of the lysate for each). Total RNAwas extracted using
the RNeasy Mini Kit (50) (QIAGEN) after pre-treating the lysate with 10 U TurboDNase (Thermo Scientific). cDNA libraries were pre-
pared using the TruSeq RNA Sample Prep Kit (Illumina), according to the manufacturers’ instructions.
Ribosome profiling was performed according to the original protocol (Ingolia et al., 2012) with the modifications described in
Calviello et al. (2016). Cell lysates were treated with 300 U RNase 1 (Thermo Scientific). Reactions were stopped after 45 min in-
cubation at room temperature by adding 80 U SUPERase Inhibitor (Thermo Scientific). The RNase 1-treated samples were applied
to MicroSpin S-400 HR columns (GE Healthcare) to remove free nucleotides and recover the ribosome-protected RNA. RNA
extraction was then performed with TriFast FL (Peqlab Biotechnologies) and the RNA Clean & Concentrator Kit (Zymo Research).
rRNA was depleted using the Ribo-Zero Gold rRNA Depletion Kit (Illumina, discontinued). Ribosome footprints were excised and
extracted from a 17% TBE-Urea gel using 30 and 27 nt RNA oligonucleotides as markers. Ribosome footprints were treated with
T4 PNK (NEB) and purified using P:C:I (PanReac AppliChem). 30 and 50 adapters were ligated using T4 RNA ligase 2, truncated
K227Q (NEB) and T4 RNA ligase 1 (NEB), respectively. Following adaptor ligation, the resulting ribosome footprints were excised
and extracted from a 15% TBE-Urea gel. Adaptor-ligated ribosome footprints were reversed transcribed with SuperScript III
(Thermo Scientific). cDNA was PCR amplified using Phusion DNA polymerase (Thermo Scientific). PCR amplicons were visualized
on a 2.5% low melting agarose (Serva Electrophoresis), excised and purified using the Zymoclean Gel DNA Recovery Kit (Zymo
Research). DNA and sample quality were assessed using the Bioanalyzer system (Agilent). The sequences of the oligonucleotides
used in this protocol are listed in Table S7.
Two biological replicates were analyzed. The ribosome profiling and total RNA libraries were sequenced using the Hiseq 3000
sequencing system (Illumina). Ribosomal RNA reads were filtered using Bowtie 2 (Langmead and Salzberg, 2012). Remaining reads
were mapped on the hg19 (UCSC) human genome with TopHat2 (Kim et al., 2013). For RNA sequencing, 17.0-21.5 million reads were
mapped (>87%).Ribosomeprofiling readswereanalyzed for three-nucleotideperiodicityusing theRiboTaperprogramto identify actively
translating ribosomes (Calviello et al., 2016). Reads corresponding to the lengths of 29 and 30 nucleotideswere selected as they showed
the most significant three nucleotide periodicity and were then used for subsequent mapping on the human genome with TopHat2. For
ribosome profiling, 6.1-9.6 million reads (> 95%) of input reads were mapped. Read count analysis was performed with the R/Bio-
conductorpackageQuasR (Gaidatzis etal., 2015).Differential expressionanalysis andmultidimensional scaling (MDS)analysiswerecon-
ducted using edgeR (McCarthy et al., 2012; Robinson et al., 2010) for selected genes with a threshold of ‘fragments per kilobase of tran-
script per million mapped reads’ (FPKM) > 2. Translation efficiency (TE) was calculated with the RiboDiff program (Zhong et al., 2017).
Harringtonine and LTM datasets from human HEK293 cells were downloaded from the Sequence Read Archive database (acces-
sion: SRA056377). The mouse ESC disome and human HEK293 cells disome datasets were retrieved from the GEO database. The
respective accession numbers are GSE134020 and GSE145723. Ribosomal RNA reads were filtered using Bowtie 2 (Langmead and
Salzberg, 2012). The remaining reads were mapped on the hg19 (UCSC) human genome or the mm9 (UCSC) mouse genome with
TopHat2 (Kim et al., 2013). No specific filters for read length were applied.
Data analysis
Upregulated and downregulated gene groups were defined as being significantly regulated (FDR < 0.005) with a log2FC > 0 and
log2FC < 0, respectively. No cutoff on the log2FC value was applied so that genes with little but significant changes could also be
detected. GO analysis was performed with the R based package GOseq (Young et al., 2010). The % of genes within each category
corresponds to the number of genes belonging to the category and upregulated in the null cells divided by the total number of upre-
gulated genes in HEK293T cells.
UniProt information was retrieved to analyze the presence of a signal peptide or the cellular location of the proteins encoded by
4EHP and GIGYF1/2 target mRNAs. Ribosome footprint density plots for individual sequencing tracks were visualized using the Inte-
grative Genomics Viewer (IGV) visualization tool (Robinson et al., 2011; Thorvaldsdóttir et al., 2013).
Ribosome pause scores were determined for each of the common and upregulated mRNAs in 4EHP- and GIGYF1/2 null
cells. Maximum (pause site) and median RFP coverage in the CDS of each transcript was retrieved using UCSC annotation ande5 Cell Reports 33, 108262, October 13, 2020
Article
ll
OPEN ACCESSRibo-Seq data in GIGYF1/2 null cells replicate number 1. The pause score refers to the reads at the pause position divided bymedian
reads in the gene. The values are listed in Table S4.
Transfections, northern and western blotting
In the rescue assays described in Figures 3, 5, 6, 7, S2, and S3, 0.64 3 106 Ctrl cells or 0.7 3 106 null cells were transfected, after
seeding in 6-well plates, using Lipofectamine 2000 (Invitrogen). The transfection mixtures contained different amounts of the plas-
mids expressing lN-HA- or V5-SBP-fusion proteins (lN-HA/V5-SBP-MBP: 0.25 mg; 4EHP: 0.25 mg of WT and cap* mutant, or
0.35 mg of S* mutant) and the GFP-fusion proteins (MBP: 0.4 mg, GIGYF1: 0.5 mg of WT, C*, GYF* and DDX6* mutants; GIGYF2:
1.75 mg of WT, 1.1 mg of C* or 1.35 mg of GYF* and DDX6* mutants). In the experiments shown in Figures 4, 5, and 6, the transfection
mixtures contained plasmids expressing DBNDD2-HA, DBNDD2-STOPx-HA, DBNDD2-FDE25-AAA-HA or DBNDD2-DPN4-AAA-HA
(0.2 mg), and LGALS3BP-HA, LGALS3BP-STOPx-HA, R-LUC, SPLGALS3BP-R-LUC or SPNPTX1-R-LUC (0.5 mg). In the assay with the 3
0
UTR reporters, the transfection mixtures contained 0.5 mg of R-LUC-DBNDD2-30 UTR, R-LUC-LGALS3BP-30 UTR or R-LUC, and
0.25 mg of F-LUC-GFP plasmid DNA.
Cells were harvested two days after transfection and firefly and Renilla luciferase activities were measured using the Dual-Lucif-
erase reporter assay system (Promega). Total RNA was isolated using TriFast (Peqlab biotechnologies). For Northern blotting, total
RNA was separated in 2% glyoxal agarose gels and blotted onto a positively charged nylon membrane (GeneScreen Plus, Perkin
Elmer). [32P]-labeled probes specific for each transcript were generated by linear PCR. Hybridizations were carried out in hybridiza-
tion solution (0.5 M NaP pH = 7.0, 7% SDS, 1 mM EDTA pH = 8.0) at 65C overnight. After extensive washes with washing solution
(40 mMNaP pH = 7.0, 1% SDS, 1 mM EDTA pH = 8.0), the membranes were exposed and band intensities were quantified by Phos-
phoImager. For detection of DBNDD2 and LGALS3BP cellular and reporter mRNAs, complementary and radioactively labeled
probes were designed against the CDS of the transcripts. Since the reporter constructs only harbor the CDS but no 50 and 30 se-
quences, the endogenous mRNAs are expected to run slower on an agarose gel. We observed that the signal of the transfected re-
porters is considerably stronger and does not allow the simultaneous detection of cellular and reporter mRNAs.
To test for tubulinmRNA autoregulation, control andGIGYF1/2 null HEK293T cells were grown to 70%confluency and treatedwith
nocodazole (10 mM, Sigma Aldrich) or DMSO for 3 hours as described previously (Lin et al., 2020). RNA was extracted using TRIzol
(Thermo Scientific), reverse-transcribed and analyzed by quantitative PCR (qPCR; 10% of each RNA sample) as described below.
Western blot was performed using standard methods. In brief, cells were washed with PBS and lysed with sample buffer (100 mM
Tris-HCl pH = 6.8, 4% SDS, 20% glycerol, 0.2 M DTT) followed by boiling 5 minutes at 95C and vortexing to shear genomic DNA.
After SDS-PAGE, proteins were transferred onto a nitrocellulose membrane (Santa Cruz Biotechnology) by tank transfer. Primary an-
tibodies were incubated overnight at 4C, secondary antibodies for an hour at room temperature. All western blots were developed
with freshly mixed 10A: 1B ECL solutions and 0.01%H2O2 [Solution A: 0.025% Luminol (Roth) in 0.1 M Tris-HCl pH = 8.6; Solution B:
0.11% P-Coumaric acid (Sigma Aldrich) in DMSO]. Antibodies used in this study are listed in the Key Resources Table. DBNDD2-HA
and LGALS3BP-HA band intensities were quantified using ImageJ (Schneider et al., 2012) and normalized to the band intensities of F-
LUC-GFP protein in the same experiment.
Reverse transcription (RT) and quantitative PCR (qPCR)
1 mg of RNA was mixed with 0.66 mg random hexamer primers (N6) and denatured at 72
C for 5 min. After addition of a reaction
mixture containing a final concentration of 1x RT buffer, 20 U RiboLock RNase Inhibitor (Thermo Scientific) and 1 mM dNTPs, the
RNA samples were incubated at 37C for 5 min. Incubation with RevertAid HMinus Reverse Transcriptase (200 U, Thermo Scientific)
was first performed for 10 min at 25C, and then at 42C for one hour. The RT reaction was stopped by incubating the samples for
10 min at 70C. The qPCR was performed with 1x iTaq SYBR Green Supermix (Biorad), 0.4 mM of each primer and 1 ml of the cDNA
sample. mRNA levels were determined by qPCR using sequence-specific primers for the indicated transcripts and normalized to 18S
rRNA or GAPDH mRNA abundance in the same sample. qPCR primers designed using Primer-BLAST (NCBI) are listed in Table S7.
Normalized transcript expression ratios from three independent experiments were determined using the Livak method (Livak and
Schmittgen, 2001).
Half-life experiments
To measure mRNA decay rates, cells were treated with Actinomycin D (10 mg/ml final concentration) two days post transfection or
three days after seeding and collected at the indicated time points. mRNA levels determined by Northern blotting or qPCR were
normalized to the levels of TUBB or 18S rRNA, respectively. Steady state TUBB mRNA levels remain unchanged in the absence
of GIGYF1/2 (Figure 7C). These values were set to 100 at time point zero. Data points from three independent experiments were
plotted and the resulting fitting curves were determined using a one phase exponential decay equation. The R2 values associated
with the fitting of the exponential decay curves were between 0.29 and 0.99. The curves with low R2 indicate that reduction of
mRNA levels over time are not well represented by an exponential decay model whereas high R2 values indicate that the quantity
of mRNA decreases at a rate proportional to its current value. To determine the time required for the decaying quantity to fall to
half of its initial value, or half-life, a decay curve was first determined for each replica. The three values were then averaged to
have the final half-life value. The three values were also used to determine the error (standard deviation) associated with the mea-




Polysome profiles were performed as described before (Kuzuoglu-Özt€urk et al., 2016). HEK293T cells were pretreated with cyclo-
heximide (50 mg/ml) for 30 min. Lysates were prepared in lysis buffer (10 mM Tris-HCl pH = 7.4, 10 mM NaCl, 1.5 mM MgCl2,
0.5%Triton X-100, 2mMDTT, 50 mg/ml cycloheximide) and polysomes separated on a 10%–50%sucrose gradient in gradient buffer
(10 mM Tris-HCl pH 7.4, 75 mM KCl, 1.5 mM MgCl2). Polysome fractions were collected using the Teledyne Isco Density Gradient
Fractionation System. Protein from sucrose fractions was isolated by methanol extraction. In detail, 4x volumes of MetOH were
mixed with the sucrose fractions, then mixed with 1x volume of chloroform and then with 3x volumes of water. After centrifugation,
the upper phase was removed leaving the lower and inter-phases which were precipitated using 3x volumes of MetOH. Samples
were spun down and the dried pellet dissolved in 2x protein sample buffer. Fractions were analyzed by western blotting.
RNA immunoprecipitation/pulldown
To immunoprecipitate GIGYF2-bound mRNA, 3 3 106 HEK293T cells were transfected using Lipofectamine 2000 (Invitrogen) 24
hours after seeding in 10 cm plates. The transfection mixtures contained the plasmid expressing the GFP-fusion proteins (MBP:
2.5 mg, GIGYF2: 10 mg of WT, 6 mg of C*, 12 mg of GYF* and 10 mg DDX6* mutants). In Figure S3, the RNA-IP was performed in cells
treated with 2 mg/ml harringtonine for 30 min or 200 mg/ml puromycin for 45 min. In Figure 6, GFP-tagged MBP or GIGYF2 were co-
expressed with LGALS3BP-HA or LGALS3BP-STOP3-HA (5 mg). To pulldown 4EHP-bound mRNA (Figure S2), cells were co-trans-
fected with the plasmids encoding V5-SBP-fusion proteins (MBP: 1 mg, 4EHP: 12 mg of WT together with MBP and GIGYF2 C*, or
0.5 mg together with GIGYF2 WT, GYF* and DDX6*) and GFP-fusion proteins (MBP: 1 mg, GIGYF2: 5 mg of WT and DDX6*, 4 mg
of C* and 8 mg of GYF* mutants). Cells were harvested 48 hours post transfection, washed with ice cold PBS and lysed on ice for
15 minutes in 500 mL of NET buffer [50 mM Tris-HCl pH = 7.5, 150 mMNaCl, 0.1% Triton X-100, 1 mM EDTA pH = 8.0, 10% glycerol,
supplemented with 1x protease inhibitors (Roche)]. Cell debris was removed by centrifugation at 16,000 g at 4C. Input samples (5%
of the total) were collected for western blotting and qRT-PCR. To immunoprecipitate GFP-GIGYF2, the remaining lysate was then
incubated with 3 mL of anti-GFP antibody (homemade) for an hour, followed by incubation (2 hours) with protein G Sepharose resin
pre-treated with yeast RNA (250 mg of yeast RNA/100 mL of 50% slurry). For pulldown of SBP-V5-4EHP and associated RNA, cell
lysates were immediately incubated with 50 mL of a 50% slurry of streptavidin beads pre-incubated with yeast RNA. Beads were
washed 3 times with NET buffer and ressuspended in 1 mL of NET buffer without detergent. An aliquot (20% of the total) of the
bead suspension, wasmixed with SDS-PAGE sample buffer for western blotting after centrifugation to pellet the resin. The remaining
beads were used for RNA isolation with TriFast (Peqlab Biotechnologies). cDNA of the input and precipitated fractions (20% each)
was prepared and analyzed using qPCR (5% of the cDNA) as described above.
Co-immunoprecipitation (Co-IP) assays
Co-IP assays were performed in the presence of RNase A as described previously (Peter et al., 2015). HEK293T cells were grown in
10 cm dishes and transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s recommendations. The trans-
fection mixtures in Figures S1I and S1J contained 2.5 mg of GFP-MBP or GFP-GIGYF1WT, 3 mg of GFP-GIGYF1 GYF*, 10 mg of GFP-
GIGYF2 WT or 12 mg of GFP-GIGYF2 GYF*. In Figure S3B, GFP-MBP or GFP-GIGYF2 were co-expressed with V5-SBP-eL22L1
(5 mg). After transfection, cells were treated as described in the RNA-IP section, with the exception that the protein G Sepharose resin
was not incubated with yeast RNA and the samples were only used for protein analysis.
UPF1 Knockdown
In the reporter assays described in Figures S6B, S6C, and S6F, 0.64 3 106 Ctrl cells were transfected with 2 mg pSUPER-puro
scramble control or UPF1 shRNA, after seeding in 6-well plates, using Lipofectamine 2000 (Invitrogen). 24 hours after transfection
cells were treated with 5 mMpuromycin for 24 hours. Selected cells were re-seeded and re-transfected with the transfection mixtures
described above (Transfections, northern and western blotting section).
QUANTIFICATION AND STATISTICAL ANALYSES
Figures 1A, 1B, S5B, and S5C. Upregulated and downregulated genes were identified using log2Fold Change (FC) between null and
control cells > 0 or < 0, respectively, and False Discovery Rates (FDR) < 0.005.
Figures 1C, S1G, and S5F. The hypergeometric test (phyper) in R was applied to estimate the likelihood of list overlap.
Figures 1D and 1E. The quantitative value represented in the graphs corresponds to -log10(q-value) determined by theGOseq anal-
ysis tool (Young et al., 2010).
Figures 2, 4, 5, and S5. Dots represent mean value; error bars represent the standard deviation from three independent experi-
ments. The mRNA decay curves were fitted to an exponential decay with a single component. R2 values are indicated for each curve.
Figures 3, 4, 5, 6, 7, S2, S3, S4, and S6. The quantitative value that is graphed represents the mean mRNA or protein level values;
error bars represent standard deviations from three independent experiments. In the qRT-PCR experiments, normalized transcript
expression ratios from three independent experiments were determined using the Livak method (Livak and Schmittgen, 2001).e7 Cell Reports 33, 108262, October 13, 2020
